Welcome to Thrombosis Adviser

A Venous & Arterial Thrombosis Resource
For

Adviser’s Picks

  • Residual MACE in CAD: What Are the Long-Term Adverse Cardiac Events to Worry About?
    Read more
  • Rivaroxaban for Stroke Prevention in the Real World: What Have We Learned From the XANTUS Programme and Pooled Analysis?
    Read more
  • Extended Treatment of VTE: In Whom and at Which Dose?
    Read more
  • Further Advances on the Use of NOACs in Patients with AF Undergoing PCI
    Read more
  • 10 Years of Anticoagulation with the NOACs
    Read more
  • Managing Multimorbid Patient with Atrial Fibrillation
    Read more

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

Subscribe
When to use a reduced NOAC dose 02:12 min
Join the Conversation

Join the Conversation

Thrombosis Connection, A Healthcare Professionals’ Forum welcomes individuals interested in sharing, developing and fostering innovative solutions in the field of thrombosis.

Join LinkedIn Group